FDA Investigator Dennis G Kawabata
Dennis G Kawabata has inspections in 1 countries as of 20 Oct 2023. Dennis G Kawabata has collaborated with a combined 1729 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
136
Last Inspection Date:
20 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
A Williams,
Alexander M Kay,
Amy M Cramer,
Ashleigh P Barkans,
Astrida B Mattson,
Ava M Bowman,
Avery J Dennis,
Barbara J Rincon,
Brenda L Reihing,
Bryan Baker,
Bryce E Mansfield,
Carl A Anderson,
Catherine J Laufmann,
Celeta S Coves,
Celia L Silverstein,
Charles L Larson,
Christine M Parmentier,
Christopher R Czajka,
Christopher S Genther,
Creighton T Tuzon,
Cynthia L Gorveatt,
Dan G Eisenbrey,
Deborah A Nebenzahl,
Denise M Zavagno,
Dennis R Hudson,
Dianna D Wardlow Dotter,
Dolores E Price,
Donald B Mckechnie,
Eileen M Malecki,
Elmina E Akwo,
Francis J Eng,
Frank J Marciniak,
Gary L Zaharek,
Gloria J Baca, MS,
Gobiga Vanniyasingam,
Graham N Giesen,
Harperd,
Heika R Tait,
Ismael Olvera, IV,
James A Lane,
James C Henry,
James D Hildreth,
James R Fleckenstein,
James R Montero,
Jessica L Walters Moell,
Jocelyn T Ramos,
John A Hall,
John E Emmert,
Jonathan Ho,
Julian C Hanson,
K Gonzlez,
Kathryn A Krentz,
Kelly D Sheppard,
Kerri E Butler,
Lauren E Swantko,
Lawrence Y Lee, PhD,
Lisa K Capron,
Lori J Silverstein,
Lorna F Jones,
Margo C Jones,
Margo Cl Jones,
Maria Pkelly Doggett, MBA,
Marlene L Davis,
Marlo Ianm Alintanahin,
Michael F Schuette,
Michael J Lackey,
Msdap Gonzlezk,
Naakesh N Gomanie,
Nancy A Saxenian Emmons,
Nataniel Phillips Sylvain, PhD,
Norman Wong,
Paul Kawamoto,
Paul M Kawamoto,
Peter Kessler, PhD,
Philip E Ake,
Phillip M Pontikos,
Rebecca L Stephany,
Rebecca T Davis,
Robert D Tollefsen,
Rocco C Black,
S Lori Brown, PhD MPH,
Sangeeta M Khurana, PhD,
Scott A Nabe,
Sharon I Gundersen,
Sheri N Rohlf,
Sherri N Rohlf, MD,
Stanley B Eugene, BS, BME,
Stephen R Souza,
Steven R Ziser,
Sunitha K Rajaram, PhD,
Suzie L Kent,
Terri E Gibson,
Vanessa Y Jacobs,
Victor A Meo,
William R Chang,
Xiaojun Yan
Dennis G Kawabata's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more